GLOMERULAR DISEASE

Clinical trials for GLOMERULAR DISEASE explained in plain language.

Never miss a new study

Get alerted when new GLOMERULAR DISEASE trials appear

Sign up with your email to follow new studies for GLOMERULAR DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Completed 3

New drug aims to slow kidney damage in IgA nephropathy

Disease control Not yet recruiting

This Phase 2 trial tests an experimental drug called HS-10542 in 90 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. Participants will receive either a high dose, low dose, or placebo for a set period. The main goal is to see if the drug reduces prot…

Matched conditions: GLOMERULAR DISEASE

Phase: PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 11:01 UTC

GLOMERULAR DISEASE

Get alerted when new GLOMERULAR DISEASE trials appear

New drug aims to slow kidney damage in IgA nephropathy